Advisor Group
DOVA

Advisor Group’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Advisor Group’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-50
Closed -$1K – 5608
2019
Q3 		$1K Hold
50
– – ﹤0.01% 5230
2019
Q2 		$1K Hold
50
– – ﹤0.01% 5191
2019
Q1 		$0 Hold
50
– – ﹤0.01% 5426
2018
Q4 		$0 Hold
50
– – ﹤0.01% 5352
2018
Q3 		$1K Hold
50
– – ﹤0.01% 5050
2018
Q2 		$1K Hold
50
– – ﹤0.01% 4875
2018
Q1 		$1K Sell
50
-50
-50% -$1.5K ﹤0.01% 4898
2017
Q4 		$3K Buy
+100
New +$2.74K ﹤0.01% 4635

Advisor Group's DOVA Position: Q4 2019 in Review

Advisor Group sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 50 shares — an estimated $1K sold.

Advisor Group first reported a position in DOVA in Q4 2017 and held it in 8 quarters. The position peaked at $3K in Q4 2017. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • Advisor Group reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Advisor Group sold 50 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $1K.
  • Advisor Group first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
  • Advisor Group's Dova Pharmaceuticals, Inc. Common Stock position peaked at $3K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.